Pharmacological properties of AF 1161, a new psychotropic drug.
D000661:Amphetamine / Q000037:antagonists & inhibitors; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D002415:Cats; D002707:Chlordiazepoxide / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D003213:Conditioning, Psychological / Q000187:drug effects; D003864:Depression, Chemical; D004285:Dogs; D004569:Electroencephalography; D005260:Female; D006168:Guinea Pigs; D006591:Hexobarbital / Q000494:pharmacology; D006634:Histamine H1 Antagonists; D008297:Male; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D010424:Pentobarbital / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology* / Q000627:therapeutic use; D011600:Psychopharmacology; D011725:Pyridines / Q000494:pharmacology* / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D012018:Reflex / Q000187:drug effects; D012702:Serotonin Antagonists; D012890:Sleep / Q000187:drug effects; D014230:Triazoles / Q000494:pharmacology* / Q000627:therapeutic use
D006634:Histamine H1 Antagonists; D010879:Piperazines; D011725:Pyridines; D012702:Serotonin Antagonists; D014230:Triazoles; D002707:Chlordiazepoxide; D009020:Morphine; D006591:Hexobarbital; D000661:Amphetamine; D010424:Pentobarbital; D002746:Chlorpromazine